drugset / Trial / NCT05428683
Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery
NaSingle-groupOpen-labelTreatment
Summary
This study aims to evaluate the short-term effects and safety of prophylactic intra-vitreal injection of triamcinolone-moxifloxacin combination after cataract surgery. 84 patients underwent cataract surgery associated with intra-vitreal injection of triamcinolone-moxifloxacin combination after surgery.
Timeline
- Start
- 2020-12-03
- Primary completion
- 2021-08-17
- Completion
- 2021-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | 0.2 mg | Intravitreal |
| Subject | Triamcinolone Acetonide | Other / unclassified | 4 mg | Intravitreal |
Indications
No indication recorded.